Dominvs Group funds new medical study into long-Covid

Related Topics

Dominvs Group, the London-based real estate development and investment group, will fund for a new landmark clinical study into long-Covid as it ramps ups the activity of its CSR arm, Dominvs In Action, to help the country bounce back from the impact of the pandemic. 

The new investigation, led by a trio of the UK's most prominent researchers, will focus on the nature of the changes to the immune system of patients suffering from long-Covid. 
  
Led by Dr Paul Glynne, the project will analyse blood samples to identify any common abnormalities in the immune cells of long-Covid patients. Glynne is the Medical Director of The Physicians' Clinic and Consultant Physician at UCLH. 
 
Some 10 per cent of people who contract Covid-19 will develop long-Covid, very often after having only mild symptoms with the acute infection; and as the pandemic continues, long-Covid is predicted to become an increasing clinical problem. It is unknown why some patients develop long-Covid while most do not, and currently no evidence-based treatments are available for it. 
 
The study has been launched this month after the researchers were granted a GBP20,000 donation from Dominvs Group in its effort to support the nation’s economic recovery this year and the continued development to find new treatments for long-Covid. 
 
Rani Ahluwalia, Chair of Dominvs In Action, says: "We are delighted to be supporting this essential clinical research. There is a need for funding to support evidence-based research into Covid-19, especially the sometimes-overlooked area of long-Covid. 
 
"We may be sadly living with coronavirus for many years yet, and we must understand its underlying causes so that we can devise successful interventions. In the face of a truly national crisis, the private sector has an important role in supporting this type of clinical research. We are delighted to be supporting this very important work." 
 
The study will sample blood from 100 participants, all individuals who have previously had Covid, some who have since fully recovered and others who have gone on to experience symptoms of long-Covid. 
 
Long-Covid symptoms are typically multi-system in their presentation, comprising fever and fatigue; anxiety, insomnia and brain fog; headaches and pins and needles; breathlessness and chest pain; diarrhoea and food intolerances, as well as rashes and vascular changes. 
 
Glynne says: "There is an urgent need for more clinical research into long-Covid. Anecdotal reports of ongoing inflammation in long-Covid, not typically measurable in routine blood tests, have prompted interest in exploring the nature of this inflammation further. We are immensely thankful for the support of Dominvs Group, which will enable us to see this important research through to completion." 
 
The Physicians' Clinic, a leading private clinic in Central London, will house the research in collaboration with HCA Healthcare UK, and the investigators plan to publish their findings later this year. The co-investigators on the project are Dr. Rajeev Gupta and Dr. Vanya Gant, with coordination support from Natasha Tahmasebi. 
 
The research has been supported by Dominvs In Action, London-based property investment firm Dominvs Group's CSR arm. The donation follows fast on the heels of the Group's support for the British Urology Researchers in Surgical Training (BURST) last year, as the Group continues to increase its support for high-impact medical and clinical research.